Nov 18th 2020
Dec 2nd 2020
Dec 8-21 2020
Nov 18th 2020
Dec 2nd 2020
Dec 8-21 2020
Pfizer and BionTech complete phase 3
Following the completion of Phase 2 of the trial , Pfizer and BionTech reported on November 18 , 2020 the completion of its worldwide third phase in which their mRNA-based COVID- 19 vaccine candidate - BNT162b2 - met all primary efficacy endpoints .
MHRA gives temporary authorisation for the vaccine
December 2 , 2020 saw the Medicines & Healthcare Products Regulatory Agency ( MHRA ) in the U . K . grant temporary authorisation for the use of the COVID- 19 mRNA vaccine . Marking the first authorisation of the vaccine following its worldwide
UK , US and Asia administer first doses of Pfizer vaccine
Six days after the temporary authorisation granted by MHRA - the UK administered its first dose of the Pfizer / BionTech vaccine . Seven days after the UK , the US administered its first dose on December 14 , 2020 , and on December 21 , 2020 Singapore received Asia ’ s first batch of the Pfizer / BionTech vaccine .
businesschief . com 19